The expanding relevance of nuclear mTOR in carcinogenesis

References

• Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12:21 - 35; PMID: 21157483; http://dx.doi.org/10.1038/nrm3025
   PubMed Web of Science ®Google Scholar
• Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007; 12:9 - 22; PMID: 17613433; http://dx.doi.org/10.1016/j.ccr.2007.05.008
   PubMed Web of Science ®Google Scholar
• Wander SA, Hennessy BT, Slingerland JM. Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest 2011; 121:1231 - 1241; PMID: 21490404; http://dx.doi.org/10.1172/JCI44145
   PubMed Web of Science ®Google Scholar
• Pani G. P66SHC and ageing: ROS and TOR?. Aging (Albany NY) 2010; 2:514 - 518; PMID: 20689155
   PubMedGoogle Scholar
• Zeng LH, McDaniel S, Rensing NR, Wong M. Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?. Cell Cycle 2010; 9:2281 - 2285; PMID: 20603607; http://dx.doi.org/10.4161/cc.9.12.11866
   PubMed Web of Science ®Google Scholar
• Narita M, Young AR, Arakawa S, Samarajiwa SA, Nakashima T, Yoshida S, et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 2011; 332:966 - 970; PMID: 21512002; http://dx.doi.org/10.1126/science.1205407
   PubMed Web of Science ®Google Scholar
• Drenan RM, Liu X, Bertram PG, Zheng XF. FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus. J Biol Chem 2004; 279:772 - 778; PMID: 14578359; http://dx.doi.org/10.1074/jbc.M305912200
   PubMed Web of Science ®Google Scholar
• Liu X, Zheng XF. Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin. Mol Biol Cell 2007; 18:1073 - 1082; PMID: 17215520; http://dx.doi.org/10.1091/mbc.E06-05-0406
   PubMed Web of Science ®Google Scholar
• Desai BN, Myers BR, Schreiber SL. FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci USA 2002; 99:4319 - 4324; PMID: 11930000; http://dx.doi.org/10.1073/pnas.261702698
   PubMed Web of Science ®Google Scholar
• Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids. Cell 2010; 141:290 - 303; PMID: 20381137; http://dx.doi.org/10.1016/j.cell.2010.02.024
   PubMed Web of Science ®Google Scholar
• Wang X, Proud CG. mTORC1 signaling: what we still don't know. J Mol Cell Biol 2011; 3:206 - 220; PMID: 21138990; http://dx.doi.org/10.1093/jmcb/mjq038
   PubMed Web of Science ®Google Scholar
• Zhang X, Shu L, Hosoi H, Murti KG, Houghton PJ. Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. J Biol Chem 2002; 277:28127 - 28134; PMID: 12000755; http://dx.doi.org/10.1074/jbc.M202625200
   PubMed Web of Science ®Google Scholar
• Bachmann RA, Kim JH, Wu AL, Park IH, Chen J. A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. J Biol Chem 2006; 281:7357 - 7363; PMID: 16407298; http://dx.doi.org/10.1074/jbc.M512218200
   PubMed Web of Science ®Google Scholar
• Wei Y, Zheng XFS. TORC1 association with rDNA chromatin as a mechanism to co-regulate Pol I and Pol III. Cell Cycle 2009; 8:3802 - 3803; PMID: 19934660; http://dx.doi.org/10.4161/cc.8.23.10039
   PubMed Web of Science ®Google Scholar
• Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1[agr] transcriptional complex. Nature 2007; 450:736 - 740; PMID: 18046414; http://dx.doi.org/10.1038/nature06322
   PubMed Web of Science ®Google Scholar
• Jiang Y. mTOR goes to the nucleus. Cell Cycle 2010; 9:868; PMID: 20348849; http://dx.doi.org/10.4161/cc.9.5.11070
   PubMed Web of Science ®Google Scholar
• Park IH, Bachmann R, Shirazi H, Chen J. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. J Biol Chem 2002; 277:31423 - 31429; PMID: 12087098; http://dx.doi.org/10.1074/jbc.M204080200
   PubMed Web of Science ®Google Scholar
• Kantidakis T, Ramsbottom BA, Birch JL, Dowding SN, White RJ. mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc Natl Acad Sci USA 2010; 107:11823 - 11828; PMID: 20543138; http://dx.doi.org/10.1073/pnas.1005188107
   PubMed Web of Science ®Google Scholar
• Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, Teruya-Feldstein J, et al. PML inhibits HIF-1[alpha] translation and neoangiogenesis through repression of mTOR. Nature 2006; 442:779 - 785; PMID: 16915281; http://dx.doi.org/10.1038/nature05029
   PubMed Web of Science ®Google Scholar
• Shen C, Lancaster CS, Shi B, Guo H, Thimmaiah P, Bjornsti MA. TOR signaling is a determinant of cell survival in response to DNA damage. Mol Cell Biol 2007; 27:7007 - 7017; PMID: 17698581; http://dx.doi.org/10.1128/MCB.00290-07
   PubMed Web of Science ®Google Scholar
• Chabes A, Georgieva B, Domkin V, Zhao X, Rothstein R, Thelander L. Survival of DNA Damage in Yeast Directly Depends on Increased dNTP Levels Allowed by Relaxed Feedback Inhibition of Ribonucleotide Reductase. Cell 2003; 112:391 - 401; PMID: 12581528; http://dx.doi.org/10.1016/S0092-8674(03)00075-8
   PubMed Web of Science ®Google Scholar
• Back JH, Rezvani HR, Zhu Y, Guyonnet-Duperat V, Athar M, Ratner D, et al. Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1. J Biol Chem 2011; 286:19100 - 19108; PMID: 21471201; http://dx.doi.org/10.1074/jbc.M111.240598
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344 - 352; PMID: 20606252
   PubMedGoogle Scholar
• Rodríguez-Jiménez FJ, Moreno-Manzano V, Mateos-Gregorio P, Royo I, Erceg S, Murguia JR, et al. FM19G11: A new modulator of HIF that links mTOR activation with the DNA damage checkpoint pathways. Cell Cycle 2010; 9:2803 - 2813; PMID: 20676050; http://dx.doi.org/10.4161/cc.9.14.12250
   PubMed Web of Science ®Google Scholar
• Land SC, Tee AR. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 2007; 282:20534 - 20543; PMID: 17502379; http://dx.doi.org/10.1074/jbc.M611782200
   PubMed Web of Science ®Google Scholar
• Tsang CK, Liu H, Zheng XFS. mTOR binds to the promoters of RNA polymerase I- and -III transcribed genes. Cell Cycle 2010; 9:953 - 957; PMID: 20038818; http://dx.doi.org/10.4161/cc.9.5.10876
   PubMed Web of Science ®Google Scholar
• Schalm SS, Blenis J. Identification of a conserved motif required for mTOR signaling. Curr Biol 2002; 12:632 - 639; PMID: 11967149; http://dx.doi.org/10.1016/S0960-9822(02)00762-5
   PubMed Web of Science ®Google Scholar
• Schalm SS, Fingar DC, Sabatini DM, Blenis J. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr Biol 2003; 13:797 - 806; PMID: 12747827; http://dx.doi.org/10.1016/S0960-9822(03)00329-4
   PubMed Web of Science ®Google Scholar
• Lee VH, Healy T, Fonseca BD, Hayashi A, Proud CG. Analysis of the regulatory motifs in eukaryotic initiation factor 4E-binding protein 1. FEBS J 2008; 275:2185 - 2199; PMID: 18384376; http://dx.doi.org/10.1111/j.1742-4658.2008.06372.x
   PubMed Web of Science ®Google Scholar
• Dunlop EA, Tee AR. Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell Signal 2009; 21:827 - 835; PMID: 19166929; http://dx.doi.org/10.1016/j.cell-sig.2009.01.012
   PubMed Web of Science ®Google Scholar
• Saksouk N, Avvakumov N, Champagne KS, Hung T, Doyon Y, Cayrou C, et al. HBO1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail. Mol Cell 2009; 33:257 - 265; PMID: 19187766; http://dx.doi.org/10.1016/j.molcel.2009.01.007
   PubMed Web of Science ®Google Scholar
• Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141:583 - 594; PMID: 20478252; http://dx.doi.org/10.1016/j.cell.2010.04.020
   PubMed Web of Science ®Google Scholar
• Schewe DM, Aguirre-Ghiso JA. ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc Natl Acad Sci USA 2008; 105:10519 - 10524; PMID: 18650380; http://dx.doi.org/10.1073/pnas.0800939105
   PubMed Web of Science ®Google Scholar